To assay the contribution of HIF-1α to the opposing expression of MISTR1 (NDUFA4) and MISTRH, we leveraged that HIF-signaling is constitutively active in many kidney cancers due to loss of the Von Hippel–Lindau (VHL) tumor suppressor [47]. Here, VHL is linked to kidney cancer.